Relative contraindication to midhumeral block in a patient with contraceptive implant.

J. Hotton,G. Salvignol,H. Bouaziz
DOI: https://doi.org/10.1213/01.ANE.0000263060.95757.D9
2007-07-01
Abstract:To the Editor: A 34-yr-old female presented for a surgical cure of trapezio-metacarpal osteoarthritis of the thumb. A midhumeral block was chosen because the patient feared general anesthesia and also desired postoperative analgesia. Once the needle insertion site had been located based on classical landmarks, the patient informed the anesthesiologist that an implant had been inserted in the medial aspect of her arm (1). The procedure was immediately stopped and the implant was easily palpated close to the planned needle insertion site. We then performed an axillary block which was uneventful as was the surgical procedure. Implanon is the trade name for a progesterone contraceptive implant produced by Organon. It is a single rod-shaped nonbiodegradable implant that contains 68 mg of desogestrel metabolite etonogestrel which is released for at least 3 yr after which it should be replaced (2). It has a length of 4 cm and a diameter of 2 mm and is usually inserted just under the skin in the subdermis on the medial aspect of the nondominant upper arm, 6–8 cm above the elbow. Puncture of the device by the stimulating needle might possibly rupture the implant, resulting in its dysfunction (3). The rod may not be palpable after incorrect insertion, significant weight gain after insertion, or possible migration (4,5). When confronted with the clinical management of a patient with a nonpalpable Implanon, ultrasound is accurate in detecting the absence or presence of the device with a specificity and sensitivity of 95.7% and 85.7%, respectively (Fig. 1) (6). Anesthesiologists should be alert that the implant may be present and if necessary modify their treatment plan to stay away from the device.
What problem does this paper attempt to address?